Further investigations on the significance of a plasma coagulation-accelerating factor in glomerular disease. 1987

M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth

The prevalence of the coagulation acceleration factor (CAF) in patients with renal disease (predominantly glomerulonephritis) has been investigated. The relationship between the activated partial thromboplastin time, F.VIII:C/vWf, prekallikrein, plasminogen and the pathogenesis of glomerulonephritis was also investigated. One hundred and seventeen patients were entered into the study on the basis of admission for renal biopsy. Thirteen percent of the patients showed evidence for CAF and 15% of patients were found to have reduced levels of plasma prekallikrein; however, no correlation was found between any of the variables measured and the type, activity or progression of glomerular disease in these patients.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D011288 Prekallikrein A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease. Fletcher Factor,Plasma Prokallikrein,Kallikreinogen,Plasma Prokallikrein A,Factor, Fletcher,Prokallikrein A, Plasma,Prokallikrein, Plasma
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney

Related Publications

M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
March 1985, British journal of haematology,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
February 1989, Journal of immunology (Baltimore, Md. : 1950),
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
January 1956, American journal of ophthalmology,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
July 1956, Quarterly journal of experimental physiology and cognate medical sciences,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
August 1965, The American journal of medicine,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
March 1956, Polski tygodnik lekarski,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
January 1950, Medycyna doswiadczalna i mikrobiologia,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
January 1961, Quarterly journal of experimental physiology and cognate medical sciences,
M A Howard, and P S Kincaid-Smith, and B G Firkin, and J A Whitworth
September 1955, The Medical journal of Australia,
Copied contents to your clipboard!